Serum levels of FBS (P = 0.01), TG (P < 0.001), LDL-c (P = 0.02), AST (P < 0.001), ALT (P < 0.001) were higher in participants with NAFLD than the controls. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.